TCDD and CH223191 Alter T Cell Balance but Fail to Induce Anti-Inflammatory Response in Adult Lupus Mice
- PMID: 38353996
- PMCID: PMC10916358
- DOI: 10.4049/immunohorizons.2300023
TCDD and CH223191 Alter T Cell Balance but Fail to Induce Anti-Inflammatory Response in Adult Lupus Mice
Abstract
Aryl hydrocarbon receptor (AhR) responds to endogenous and exogenous ligands as a cytosolic receptor, transcription factor, and E3 ubiquitin ligase. Several studies support an anti-inflammatory effect of AhR activation. However, exposure to the AhR agonist 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) during early stages of development results in an autoimmune phenotype and exacerbates lupus. The effects of TCDD on lupus in adults with pre-existing autoimmunity have not been described. We present novel evidence that AhR stimulation by TCDD alters T cell responses but fails to impact lupus-like disease using an adult mouse model. Interestingly, AhR antagonist CH223191 also changed T cell balance in our model. We next developed a conceptual framework for identifying cellular and molecular factors that contribute to physiological outcomes in lupus and created models that describe cytokine dynamics that were fed into a system of differential equations to predict the kinetics of T follicular helper (Tfh) and regulatory T (Treg) cell populations. The model predicted that Tfh cells expanded to larger values following TCDD exposure compared with vehicle and CH223191. Following the initial elevation, both Tfh and Treg cell populations continuously decayed over time. A function based on the ratio of predicted Treg/Tfh cells showed that Treg cells exceed Tfh cells in all groups, with TCDD and CH223191 showing lower Treg/Tfh cell ratios than the vehicle and that the ratio is relatively constant over time. We conclude that AhR ligands did not induce an anti-inflammatory response to attenuate autoimmunity in adult lupus mice. This study challenges the dogma that TCDD supports an immunosuppressive phenotype.
Copyright © 2024 The Authors.
Conflict of interest statement
The authors have no financial conflicts of interest.
Figures
![FIGURE 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10916358/bin/ih2300023f1.gif)
![FIGURE 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10916358/bin/ih2300023f2.gif)
![FIGURE 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10916358/bin/ih2300023f3.gif)
![FIGURE 4.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10916358/bin/ih2300023f4.gif)
![FIGURE 5.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10916358/bin/ih2300023f5.gif)
Similar articles
-
From Suppressor T cells to Regulatory T cells: How the Journey That Began with the Discovery of the Toxic Effects of TCDD Led to Better Understanding of the Role of AhR in Immunoregulation.Int J Mol Sci. 2020 Oct 22;21(21):7849. doi: 10.3390/ijms21217849. Int J Mol Sci. 2020. PMID: 33105907 Free PMC article. Review.
-
2,3,7,8‑tetrachlorodibenzo‑p‑dioxin suppresses the growth of human colorectal cancer cells in vitro: Implication of the aryl hydrocarbon receptor signaling.Int J Oncol. 2019 Apr;54(4):1422-1432. doi: 10.3892/ijo.2019.4703. Epub 2019 Jan 30. Int J Oncol. 2019. PMID: 30720065 Free PMC article.
-
Transient suppression of AHR activity in early red seabream embryos does not prevent the disruption of peripheral nerve projection by 2,3,7,8-tetrachlorodibenzo-p-dioxin.Aquat Toxicol. 2014 Sep;154:39-47. doi: 10.1016/j.aquatox.2014.05.001. Epub 2014 May 10. Aquat Toxicol. 2014. PMID: 24858342
-
The possible roles of environmental factors and the aryl hydrocarbon receptor in the prevalence of thyroid diseases in Vietnam era veterans.Curr Opin Endocrinol Diabetes Obes. 2011 Oct;18(5):315-20. doi: 10.1097/MED.0b013e32834a8764. Curr Opin Endocrinol Diabetes Obes. 2011. PMID: 21825977 Review.
-
Activation of aryl hydrocarbon receptor by TCDD prevents diabetes in NOD mice and increases Foxp3+ T cells in pancreatic lymph nodes.Immunotherapy. 2009 Jul;1(4):539-47. doi: 10.2217/imt.09.24. Immunotherapy. 2009. PMID: 20174617 Free PMC article.
References
-
- Lamas, B., Natividad J. M., Sokol H.. 2018. Aryl hydrocarbon receptor and intestinal immunity. Mucosal Immunol. 11: 1024–1038. - PubMed
-
- Von Burg, R. 1988. TCDD. J. Appl. Toxicol. 8: 145–148. - PubMed
-
- Saberi Hosnijeh, F., Portengen L., Bueno-de-Mesquita H. B., Heederik D., Vermeulen R.. 2013. Circulating soluble CD27 and CD30 in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Cancer Epidemiol. Biomarkers Prev. 22: 2420–2424. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources